BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria

Macrae, F, Bowman, P, Linton, E et al. (9 more authors) (2018) BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria. In: British Journal of Haematology. 58th Annual Scientific Meeting of the British Society for Haematology, 16-18 Apr 2018, Liverpool, UK. Wiley , p. 130.

Metadata

Authors/Creators:

Macrae, F
Bowman, P
Linton, E
Peacock-Young, B
Clarke, D
Newton, D https://orcid.org/0000-0002-0214-1486
McKinley, C https://orcid.org/0000-0003-4006-8846
Riley, K
Copeland, N
Arnold, L
Ariens, R https://orcid.org/0000-0002-6310-5745
Hill, A

Keywords:

clotting; eculizumab; fibrinogen; paroxysmal nocturnal haemoglobinuria; thrombosis

Dates:

Published (online): 16 April 2018
Published: April 2018

Institution:

The University of Leeds

Academic Units:

The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)

Funding Information:

Funder	Grant number
British Heart Foundation	PG/16/60/32292

Depositing User:

Symplectic Publications

Date Deposited:

18 Feb 2020 15:58

Last Modified:

18 Feb 2020 15:58

Status:

Published

Publisher:

Wiley

Identification Number:

https://doi.org/10.1111/bjh.15226

Related URLs:

Author

CORE (COnnecting REpositories)

BSH18-PO-150: Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria

Metadata

Download not available

Export

Statistics